Big relief for medical device makers in India

The Indian government has given relief by asking them to skip considering the need for US and European regulatory certification for the device to be bought for state-run institutions and hospitals. This will act as a booster for medical equipment makers in India Medical Device Makers

To help local manufacturers, the Government has excluded them from the stipulation for the US or European regulatory approval, freed them from tenders and to level the playing field.  During public procurement, the Department of Pharmaceuticals said that to support the movement of Make In India, it is favorable that our country needs to prefer India made products.

Procurement tenders for medical devices by institutions and government hospitals typically ask for certified products by the US Food and Drug Administration, stamped with the CE mark derived from the European Medical Device Directives OR approved by India’s drug controller general. And Indian medical device makers, always alleged that these conditions are discriminatory and favor multinational companies.

One of the Indian device manufacturers shared with the media that domestic device makers usually face a lot of discrimination even if they have an approval certificate from India’s drug regulatory certification. And the condition of having certification from foreign countries by some states and institutions clearly states that they favor MNCs.

PD Vaghela DoP secretary also said that the “restrictive” and “discriminatory” tender conditions affect the domestic industry growth as domestic makers not able to get the benefit of government contracts.

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India